Treatment of refractory pyoderma gangrenosum with intravenous immunoglobulin

被引：24
|
作者：
de Zwaan, Sally E. [3 ]
Iland, Harry J. [1 ]
Damian, Diona L. [2 ,3 ]
机构：
[1] Royal Prince Alfred Hosp, Dept Haematol, Sydney, NSW, Australia
[2] Univ Sydney, Dept Dermatol, Sydney, NSW 2006, Australia
[3] Royal Prince Alfred Hosp, Dept Dermatol, Sydney, NSW, Australia
来源：
AUSTRALASIAN JOURNAL OF DERMATOLOGY | 2009年 / 50卷 / 01期
关键词：
corticosteroid adverse effects; diabetes mellitus; imatinib mesylate;
D O I：
10.1111/j.1440-0960.2008.00506.x
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
We report a patient with pyoderma gangrenosum successfully treated with intravenous immunoglobulin. He had previously been treated for 4 years with high-dose corticosteroids and had developed insulin-dependent diabetes mellitus. Multiple corticosteroid-sparing agents had failed or were contraindicated. He developed no adverse effects from intravenous immunoglobulin, which allowed reduction of his prednisone to 3 mg/day, and his ulcer has completely healed.
引用
收藏
页码：56 / 59
页数：4
相关论文
共 50 条
  • [1] Intravenous immunoglobulin treatment for refractory pyoderma gangrenosum
    Nguyen, Jacqueline K.
    Holmes, Zachary
    Kelly, Robert I.
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2023, 64 (02) : 221 - 228
  • [2] Treatment of pyoderma gangrenosum with intravenous immunoglobulin
    Cummins, D. L.
    Anhalt, G. J.
    Monahan, T.
    Meyerle, J. H.
    BRITISH JOURNAL OF DERMATOLOGY, 2007, 157 (06) : 1235 - 1239
  • [3] Treatment of severe, refractory pyoderma gangrenosum with infliximab, adalimumab and intravenous immunoglobulin
    Holmes, Zack
    Nguyen, Jacqueline
    Courtney, Ashling
    Kelly, Robert
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2023, 64 : 60 - 60
  • [4] Treatment of severe, refractory pyoderma gangrenosum with infliximab, adalimumab and intravenous immunoglobulin
    Holmes, Zachary
    Nguyen, Jacqueline
    Courtney, Ashling
    Jobson, Dale
    Kelly, Robert
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2023, 64 (03) : 433 - 435
  • [5] A case of refractory pyoderma gangrenosum treated with intravenous immunoglobulin
    Duhovic, Chris
    Duarte-Williamson, Emilia
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2016, 74 (05) : AB165 - AB165
  • [6] Intravenous immunoglobulin for pyoderma gangrenosum
    Kreuter, A.
    Reich-Schupke, S.
    Stuecker, M.
    Altmeyer, P.
    Gambichler, T.
    BRITISH JOURNAL OF DERMATOLOGY, 2008, 158 (04) : 856 - 857
  • [7] Successful treatment of severe refractory post-cesarean pyoderma gangrenosum with intravenous immunoglobulin
    Gunduz, Kamer
    Gulbasaran, Fatmagul
    Hasdemir, Pinar Solmaz
    Temiz, Peyker
    Inanir, Isil
    DERMATOLOGIC THERAPY, 2020, 33 (06)
  • [8] Clinical factors influencing response to intravenous immunoglobulin treatment in cases of refractory pyoderma gangrenosum
    Haag, C.
    Keller, J.
    Ortega-Loayza, A.
    Fett, N.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2018, 138 (05) : S61 - S61
  • [9] Successful treatment of pyoderma gangrenosum with intravenous human immunoglobulin
    Dirschka, T
    Kastner, U
    Behrens, S
    Altmeyer, P
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1998, 39 (05) : 789 - 790
  • [10] Successful Treatment of Pyoderma gangrenosum in Pregnancy with intravenous Immunoglobulin Administration
    Erfurt-Berge, C.
    Herbst, C.
    Schuler, G.
    Bauerschmitz, J.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2011, 9 : 248 - 248
12345